Platinum-sensitive Recurrent Ovarian Cancer Patients Previously Treated With a PARP Inhibitor
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Niraparib and Bevacizumab Maintenance Therapy in Platinum-sensitive Recurrent Ovarian Cancer Patients Previously Treated With a PARP Inhibitor (NCT04734665) | Yonsei University | 2021-07-05 |
Track Platinum-sensitive Recurrent Ovarian Cancer Patients Previously Treated With a PARP Inhibitor automatically
Every clearance here is in the API, with alerts when new ones post.